DE602005010213D1 - Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens - Google Patents

Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens

Info

Publication number
DE602005010213D1
DE602005010213D1 DE602005010213T DE602005010213T DE602005010213D1 DE 602005010213 D1 DE602005010213 D1 DE 602005010213D1 DE 602005010213 T DE602005010213 T DE 602005010213T DE 602005010213 T DE602005010213 T DE 602005010213T DE 602005010213 D1 DE602005010213 D1 DE 602005010213D1
Authority
DE
Germany
Prior art keywords
zonisamide
osa
diagnosis
treatment
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005010213T
Other languages
English (en)
Inventor
Jan Hedner
Ludger Grote
Kaj Stenloef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cereuscience AB
Original Assignee
Cereuscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cereuscience AB filed Critical Cereuscience AB
Publication of DE602005010213D1 publication Critical patent/DE602005010213D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Test And Diagnosis Of Digital Computers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Emergency Protection Circuit Devices (AREA)
DE602005010213T 2004-02-17 2005-02-15 Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens Active DE602005010213D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400378A SE0400378D0 (sv) 2004-02-17 2004-02-17 Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
PCT/SE2005/000196 WO2005077362A1 (en) 2004-02-17 2005-02-15 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method

Publications (1)

Publication Number Publication Date
DE602005010213D1 true DE602005010213D1 (de) 2008-11-20

Family

ID=31974257

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005010213T Active DE602005010213D1 (de) 2004-02-17 2005-02-15 Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens

Country Status (14)

Country Link
US (1) US7655681B2 (de)
EP (1) EP1715859B1 (de)
JP (1) JP2007523079A (de)
CN (1) CN100558358C (de)
AT (1) ATE410163T1 (de)
AU (1) AU2005212149B2 (de)
CA (1) CA2555149C (de)
DE (1) DE602005010213D1 (de)
DK (1) DK1715859T3 (de)
ES (1) ES2317196T3 (de)
NZ (1) NZ548943A (de)
SE (1) SE0400378D0 (de)
SI (1) SI1715859T1 (de)
WO (1) WO2005077362A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2303085T3 (es) 2003-04-29 2008-08-01 Orexigen Therapeutics, Inc. Composiciones que afectan a la perdida de peso.
KR20080059208A (ko) * 2005-09-16 2008-06-26 세레우사이언스 아베 수면 호흡 장애를 예방 및 치료하는 방법과 그 수단
BRPI0618918B8 (pt) 2005-11-22 2021-05-25 Nalpropion Pharmaceuticals Llc uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea
WO2007062228A1 (en) * 2005-11-28 2007-05-31 Orexigen Therapeutics, Inc. Sustained-release formulation of zonisamide
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
MX343867B (es) 2006-11-09 2016-11-25 Orexigen Therapeutics Inc Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
MX2010012909A (es) 2008-05-30 2011-02-25 Orexigen Therapeutics Inc Metodos para tratamiento de condiciones de grasa visceral.
CA2786026A1 (en) * 2010-01-07 2011-07-14 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
AU2011203867B2 (en) 2010-01-11 2015-12-03 Nalpropion Pharmaceuticals Llc Methods of providing weight loss therapy in patients with major depression
CN115813368A (zh) * 2012-05-30 2023-03-21 瑞思迈传感器技术有限公司 用于监控心肺健康的方法和设备
EP2858640B1 (de) 2012-06-06 2020-03-25 Nalpropion Pharmaceuticals LLC Zusammensetzung zur Verwendung in einem Verfahren zur Behandlung von Übergewicht und Fettleibigkeit in Patienten mit hohem Herz-Kreislauf-Risiko
US10525219B2 (en) 2012-06-26 2020-01-07 Resmed Sensor Technologies Limited Methods and apparatus for monitoring and treating respiratory insufficiency
PL3423062T3 (pl) 2016-05-11 2020-12-28 Jan Hedner Sultiam do leczenia bezdechu sennego
CN112259179A (zh) * 2020-10-09 2021-01-22 首都医科大学宣武医院 一种患者日志生成方法及装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509349A (ja) * 1999-09-15 2003-03-11 エラン ファーマシューティカルズ，インコーポレイテッド ヘテロアリールメタンスルホンアミドを使用するニューロパシー性疼痛を処置するための方法。
SE0000601D0 (sv) 2000-02-24 2000-02-24 Jan Hedner Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
CA2483464C (en) * 2002-05-17 2011-12-20 Duke University Method for treating obesity

Also Published As

Publication number Publication date
CN1917874A (zh) 2007-02-21
US7655681B2 (en) 2010-02-02
ATE410163T1 (de) 2008-10-15
CA2555149C (en) 2014-01-21
ES2317196T3 (es) 2009-04-16
US20070281005A1 (en) 2007-12-06
SI1715859T1 (sl) 2009-06-30
DK1715859T3 (da) 2009-02-16
EP1715859B1 (de) 2008-10-08
CA2555149A1 (en) 2005-08-25
SE0400378D0 (sv) 2004-02-17
AU2005212149A1 (en) 2005-08-25
CN100558358C (zh) 2009-11-11
NZ548943A (en) 2010-06-25
JP2007523079A (ja) 2007-08-16
WO2005077362A1 (en) 2005-08-25
AU2005212149B2 (en) 2010-02-11
EP1715859A1 (de) 2006-11-02

Similar Documents

Publication Publication Date Title
DE602005010213D1 (de) Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ME02414B (de) Behandlung von morbus crohn mit laquinimod
DE602005018763D1 (de) Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
ME02495B (de) Behandlung bdnf-assoziierter erkrankungen mit laquinimod
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
NO20064964L (no) Behandling av svekket respiratorisk funksjon
BRPI0510501A (pt) antagonistas do receptor 3 de histamina
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
MY148866A (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
IN2012DN06616A (de)
DE60218193D1 (de) Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia
MX2009011900A (es) Curacion de herida diabetica.
DE60111025D1 (de) Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose
JP2004532215A (ja) 睡眠時の自律的安定性に関するカンナビノイドの機能的役割
MX2008013635A (es) Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
NO20055390L (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
EP1262197A3 (de) Kombinationstherapie zur Behandlung von Schlafstörungen, Schlaflosigkeit inbegriffen
HUP0204048A2 (hu) Dezloratadin alkalmazása allergiás és gyulladásos tünetek kezelésére
WO2006063038A3 (en) Treating sleep deprivation using anesthetic agent
EA200600284A1 (ru) Дооперационное лечение послеоперационной боли

Legal Events

Date Code Title Description
8364 No opposition during term of opposition